查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423668

2030 年体外心律调节器市场预测：按设备、应用、最终用户和地区进行的全球分析

External Pacemaker Market Forecasts to 2030 - Global Analysis By Device (Single Chamber and Dual Chamber), By Application (Acute Myocardial Infarction, Bradycardia, Heart Block and Other Applications), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球体外心律调节器市场规模为 17.6 亿美元，预测期内复合年增长率为 5.4%，到 2030 年将达到 25.4 亿美元。

体外心律调节器是医疗设备，旨在透过向外部传递电脉衝来调节心律。它由连接到外部发生器的电极组成，该发生器发出受控的电信号。该设备被放置在患者的胸部，并向心臟发送电脉衝，以解决异常心律，例如心搏过缓其他传导异常，直到实施永久解决方案。

根据美国疾病管制与预防中心 (CDC) 的数据，大约每 40 秒就有一名美国心臟病发作。每年有 805,000 名美国人心臟病发作，其中 605,000 人是首次心臟病发作。

老年人口不断增加

老年人通常会出现心率异常，例如心搏过缓或心臟传导阻滞。随着人口老化的扩大，需要起搏器介入的心臟病盛行率也在增加。在这些情况下，外部起搏器可作为临时解决方案，在患者等待永久植入时提供即时心臟支持，或作为心臟手术后的临时措施。此外，世界人口老化与起搏器需求增加直接相关，从而推动市场成长。

心律调节器高成本

儘管这些设备对于心臟管理至关重要，但它们的采购和维护成本都很高。先进的技术、材料和製造流程导致价格急剧上升。此外，某些地区的医疗保健预算限制和有限的保险覆盖范围造成了经济障碍，阻碍患者获得救生设备。

新兴国家可支配所得增加

收入水准的提高使新兴国家有可能购买先进的医疗保健服务和医疗设备，包括心律调节器。这增加了对心臟治疗的需求并增加了获得昂贵医疗技术的机会。负担能力的提高鼓励更多的人选择起搏器植入和治疗，从而推动市场成长。此外，医疗保健支出的增加和保险覆盖范围的扩大也有助于提高这些经济体的普及并改善市场形势。

与替代疗法的竞争

药物治疗、改变生活方式和其他非侵入性心臟治疗等替代疗法是起搏器植入的治疗方法疗法。对于某些心臟疾病，出于对手术、设备依赖性和成本的担忧，患者可能会在考虑起搏器之前选择替代疗法。此外，非侵入性手术的进步和替代疗法的研究可能会提供可行的选择，并立即减少对起搏器的需求。

COVID-19 的影响：

COVID-19 大流行对体外心律调节器市场产生了重大影响。医疗服务、选择性手术和医院就诊的中断导致非紧急治疗的推迟，包括起搏器植入。供应链中断和与流行病相关的医疗保健资源的优先顺序影响了设备的可得性。患者不愿就医和住院也导致心律调节器手术减少，导致市场成长暂时下降。

预计在预测期内医院部门将是最大的

在预测期内，医院部门预计将是最大的。该医院是心臟护理的主要中心，拥有专业的基础设施和熟练的医疗专业人员，能够诊断和治疗需要外部起搏器的复杂心臟病。此外，由于需要即时进行心臟治疗的患者大量涌入，这些设施是起搏器植入和管理的主要中心。该医院的综合医疗服务和专业心臟科巩固了其作为体外起搏器市场最大贡献者的地位。

预计心臟块领域在预测期内复合年增长率最高

预计心臟传导阻滞细分市场在预测期内将出现良好的成长率。这是由于心臟传导阻滞的盛行率不断增加，即心臟的电讯号被延迟或阻塞。在这种情况下，外部心律调节器是调节心律的重要临时解决方案，有助于满足不断增长的需求。此外，技术进步和人们对心臟健康意识的提高预计将推动采用外部起搏器进行心臟传导阻滞管理，从而刺激该领域的快速成长。

比最大的地区

由于其先进的医疗基础设施、心臟病的高盛行率和高昂的医疗费用，北美预计将在体外起搏器市场中占据最大的市场占有率。此外，主要市场参与者的存在和广泛的研发活动也有助于形成市场主导地位。此外，不断增加的心臟治疗技术进步倡议以及积极采用创新医疗解决方案的倡议正在加强北美在体外起搏器市场的主导地位。

复合年增长率最高的地区：

由于心臟病患病率上升和老年人口不断增加，预计亚太地区外部起搏器市场将显着增长。此外，医疗基础设施的改善、先进医疗保健意识的提高以及可支配收入的增加正在推动体外起搏器的采用率。此外，与国际医疗设备製造商的合作伙伴关係以及政府的支持措施进一步推动了市场扩张，显示亚太地区体外起搏器市场的成长前景显着。

提供免费客製化

如果您订阅此报告，我们将为您提供以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球外部心律调节器市场：依设备分类

  • 单室
  • 双腔室

第六章全球体外心律调节器市场：依应用分类

  • 急性心肌梗塞
  • 心搏过缓
  • 心臟传导阻滞
  • 术后护理
  • 心搏过速
  • 其他用途

第七章全球外部心律调节器市场：依最终用户分类

  • 医院
  • 门诊手术中心
  • 诊所
  • 家庭保健
  • 其他最终用户

第八章全球外部心律调节器市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Abbott Laboratories
  • Biotronik
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • Cook Medical
  • Galix Biomedical Instrumentation
  • LivaNova Plc
  • Medtronic
  • Osypka Medical GmbH
  • Reka Health Pte Ltd.
  • Schiller AG
  • Shree Pacetronix Ltd.
  • Spacelabs Healthcare
  • ZOLL Medical Corporation
Product Code: SMRC24902

According to Stratistics MRC, the Global External Pacemaker Market is accounted for $1.76 billion in 2023 and is expected to reach $2.54 billion by 2030 growing at a CAGR of 5.4% during the forecast period. An external pacemaker is a medical device designed to regulate heart rhythm by delivering electrical impulses externally. It consists of electrodes connected to an external generator that emits controlled electrical signals. This device is placed on the patient's chest and transmits electrical pulses to the heart, addressing abnormal heart rhythms like bradycardia or other conduction abnormalities until a permanent solution is implemented.

According to the Centers for Disease Control and Prevention (CDC), approximately every 40 seconds an American will have a heart attack. Every year, 805,000 Americans have a heart attack, 605,000 of them for the first time.

Market Dynamics:

Driver:

Growing geriatric population

Elderly individuals commonly experience heart rhythm abnormalities like bradycardia or heart block. As the ageing demographic expands, there's a higher prevalence of cardiac conditions necessitating pacemaker intervention. External pacemakers serve as temporary solutions in these cases, providing immediate cardiac support while patients await permanent implantation or temporary measure post-cardiac procedures. Additionally, the rising ageing population worldwide directly correlates with an increased demand for external pacemakers, fostering market growth.

Restraint:

High cost of pacemakers

These devices are crucial for cardiac management, but they involve substantial expenses for both procurement and maintenance. The sophisticated technology, materials, and manufacturing processes contribute to elevated prices. Additionally, healthcare budget constraints and limited insurance coverage in certain regions create financial barriers, hindering patient access to these life-saving devices, which limits their accessibility to a broader population.

Opportunity:

Increasing disposable income in emerging economies

Due to the rise in income levels, emerging economies can afford advanced healthcare services and devices, including pacemakers. This leads to a higher demand for cardiac care and better access to expensive medical technologies. Improved affordability allows a larger segment of the population to opt for pacemaker implantations or treatments, boosting market growth. Moreover, increased healthcare spending and better insurance coverage contribute to expanded adoption rates, creating a favourable market landscape in these economies.

Threat:

Competition from alternative therapies

Alternative treatments like medication, lifestyle changes, or other non-invasive cardiac interventions present alternatives to pacemaker implantation. For certain cardiac conditions, patients might opt for alternative therapies before considering a pacemaker due to concerns about surgery, device dependency, or cost. Moreover, advancements in non-invasive procedures and research into alternative treatments offer viable options, potentially reducing the immediate need for pacemakers.

Covid-19 Impact:

The COVID-19 pandemic had a substantial impact on the external pacemaker market. Disruptions in healthcare services, elective procedures, and hospital visits led to deferred non-emergency treatments, including pacemaker implantations. Supply chain disruptions and the prioritisation of resources for pandemic-related care affected device availability. Patient reluctance to seek medical care and hospitalisations also contributed to reduced pacemaker procedures, resulting in a temporary decline in market growth.

The hospitals segment is expected to be the largest during the forecast period

During the forecast period, the hospitals segment is poised to dominate. Hospitals serve as primary centres for cardiac care, equipped with specialised infrastructure and skilled healthcare professionals capable of diagnosing and treating complex cardiac conditions requiring external pacemakers. Additionally, these facilities often witness a high influx of patients requiring immediate cardiac interventions, making them primary hubs for pacemaker implantations and management. The comprehensive healthcare services and specialised cardiology departments in hospitals solidify their position as the largest contributors to the external pacemaker market.

The heart block segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the heart block segment is anticipated to experience a lucrative growth rate. This is attributed to the increasing prevalence of heart block conditions, where the heart's electrical signals are delayed or obstructed. External pacemakers serve as essential temporary solutions for regulating the heart's rhythm in such cases, contributing to their heightened demand. Additionally, advancements in technology and a growing awareness of cardiac health are expected to drive the adoption of external pacemakers for heart block management, fueling the segment's rapid growth.

Region with largest share:

North America is positioned to secure the largest market share in the external pacemaker market owing to its advanced healthcare infrastructure, high prevalence of cardiac disorders, and substantial healthcare expenditure. Additionally, the presence of key market players and extensive research and development activities contribute to market dominance. Furthermore, increasing initiatives for technological advancements in cardiac care and a proactive approach to adopting innovative medical solutions reinforce North America's prominence in the external pacemaker market.

Region with highest CAGR:

The Asia-Pacific region is poised for significant growth in the external pacemaker market due to the region's rising prevalence of cardiac disorders and an expanding geriatric population. Additionally, improving healthcare infrastructure, growing awareness about advanced medical treatments, and rising disposable incomes contribute to higher adoption rates of external pacemakers. Moreover, collaborations with international medical device manufacturers and supportive government initiatives further drive market expansion, indicating substantial growth prospects for the Asia-Pacific External Pacemaker market.

Key players in the market

Some of the key players in External Pacemaker Market include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Cardiac Science Corporation, Cook Medical, Galix Biomedical Instrumentation, LivaNova Plc, Medtronic, Osypka Medical GmbH, Reka Health Pte Ltd., Schiller AG, Shree Pacetronix Ltd., Spacelabs Healthcare and ZOLL Medical Corporation.

Key Developments:

In December 2023, Medtronic plc, a global leader in healthcare technology, announces that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals. This AI-driven partnership will further capitalize on the achievements already realized with the GI Genius™ intelligent endoscopy module, offering continued innovation and scalable healthcare advancements for patients and caregivers globally.

In November 2023, Boston Scientific Corporation announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain that is a form of chronic low back pain. The Intracept system, a basivertebral nerve ablation therapy, will be an addition to the Boston Scientific chronic pain portfolio that includes spinal cord stimulation, radiofrequency ablation and an interspinous spacer procedure.

In July 2023, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms. With more than 80% of people who need a pacemaker requiring pacing in two chambers of the heart (both the right atrium and right ventricle), the approval significantly increases access to leadless pacing for millions of people across the U.S.

Devices Covered:

  • Single Chamber
  • Dual Chamber

Applications Covered:

  • Acute Myocardial Infarction
  • Bradycardia
  • Heart Block
  • Post-Operative Care
  • Tachycardia
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Home Healthcare
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global External Pacemaker Market, By Device

  • 5.1 Introduction
  • 5.2 Single Chamber
  • 5.3 Dual Chamber

6 Global External Pacemaker Market, By Application

  • 6.1 Introduction
  • 6.2 Acute Myocardial Infarction
  • 6.3 Bradycardia
  • 6.4 Heart Block
  • 6.5 Post-Operative Care
  • 6.6 Tachycardia
  • 6.7 Other Applications

7 Global External Pacemaker Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Clinics
  • 7.5 Home Healthcare
  • 7.6 Other End Users

8 Global External Pacemaker Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Biotronik
  • 10.3 Boston Scientific Corporation
  • 10.4 Cardiac Science Corporation
  • 10.5 Cook Medical
  • 10.6 Galix Biomedical Instrumentation
  • 10.7 LivaNova Plc
  • 10.8 Medtronic
  • 10.9 Osypka Medical GmbH
  • 10.10 Reka Health Pte Ltd.
  • 10.11 Schiller AG
  • 10.12 Shree Pacetronix Ltd.
  • 10.13 Spacelabs Healthcare
  • 10.14 ZOLL Medical Corporation

List of Tables

  • Table 1 Global External Pacemaker Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
  • Table 3 Global External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
  • Table 4 Global External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
  • Table 5 Global External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
  • Table 6 Global External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
  • Table 7 Global External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
  • Table 8 Global External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
  • Table 9 Global External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
  • Table 10 Global External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
  • Table 11 Global External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 12 Global External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
  • Table 13 Global External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 14 Global External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 15 Global External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 16 Global External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
  • Table 17 Global External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 18 North America External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
  • Table 19 North America External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
  • Table 20 North America External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
  • Table 21 North America External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
  • Table 22 North America External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 North America External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
  • Table 24 North America External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
  • Table 25 North America External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
  • Table 26 North America External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
  • Table 27 North America External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
  • Table 28 North America External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 North America External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 North America External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 31 North America External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 32 North America External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 33 North America External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
  • Table 34 North America External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 35 Europe External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
  • Table 36 Europe External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
  • Table 37 Europe External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
  • Table 38 Europe External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
  • Table 39 Europe External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
  • Table 40 Europe External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
  • Table 41 Europe External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
  • Table 42 Europe External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
  • Table 43 Europe External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
  • Table 44 Europe External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
  • Table 45 Europe External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 46 Europe External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
  • Table 47 Europe External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 48 Europe External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 49 Europe External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 50 Europe External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
  • Table 51 Europe External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 52 Asia Pacific External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Asia Pacific External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
  • Table 54 Asia Pacific External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
  • Table 55 Asia Pacific External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
  • Table 56 Asia Pacific External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
  • Table 57 Asia Pacific External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
  • Table 58 Asia Pacific External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
  • Table 59 Asia Pacific External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
  • Table 60 Asia Pacific External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
  • Table 61 Asia Pacific External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
  • Table 62 Asia Pacific External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 63 Asia Pacific External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
  • Table 64 Asia Pacific External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 65 Asia Pacific External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 66 Asia Pacific External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 67 Asia Pacific External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
  • Table 68 Asia Pacific External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 69 South America External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
  • Table 70 South America External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
  • Table 71 South America External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
  • Table 72 South America External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
  • Table 73 South America External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
  • Table 74 South America External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
  • Table 75 South America External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
  • Table 76 South America External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
  • Table 77 South America External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
  • Table 78 South America External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
  • Table 79 South America External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 80 South America External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
  • Table 81 South America External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 82 South America External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 83 South America External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 84 South America External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
  • Table 85 South America External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 86 Middle East & Africa External Pacemaker Market Outlook, By Country (2021-2030) ($MN)
  • Table 87 Middle East & Africa External Pacemaker Market Outlook, By Device (2021-2030) ($MN)
  • Table 88 Middle East & Africa External Pacemaker Market Outlook, By Single Chamber (2021-2030) ($MN)
  • Table 89 Middle East & Africa External Pacemaker Market Outlook, By Dual Chamber (2021-2030) ($MN)
  • Table 90 Middle East & Africa External Pacemaker Market Outlook, By Application (2021-2030) ($MN)
  • Table 91 Middle East & Africa External Pacemaker Market Outlook, By Acute Myocardial Infarction (2021-2030) ($MN)
  • Table 92 Middle East & Africa External Pacemaker Market Outlook, By Bradycardia (2021-2030) ($MN)
  • Table 93 Middle East & Africa External Pacemaker Market Outlook, By Heart Block (2021-2030) ($MN)
  • Table 94 Middle East & Africa External Pacemaker Market Outlook, By Post-Operative Care (2021-2030) ($MN)
  • Table 95 Middle East & Africa External Pacemaker Market Outlook, By Tachycardia (2021-2030) ($MN)
  • Table 96 Middle East & Africa External Pacemaker Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 97 Middle East & Africa External Pacemaker Market Outlook, By End User (2021-2030) ($MN)
  • Table 98 Middle East & Africa External Pacemaker Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 99 Middle East & Africa External Pacemaker Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 100 Middle East & Africa External Pacemaker Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 101 Middle East & Africa External Pacemaker Market Outlook, By Home Healthcare (2021-2030) ($MN)
  • Table 102 Middle East & Africa External Pacemaker Market Outlook, By Other End Users (2021-2030) ($MN)